Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans.
The research, published in Scientific Reports, also highlights the role of lipid metabolism in maintaining the health of the retina, reporting that palmitoleic acid also had protective effects on retinal cells in culture and in mice.
The “good-for-you” compound in broccoli which prompted the inquiry is indole-3-carbinol (I3C), which is currently being studied for cancer prevention. I3C helps clear cells of environmental toxins by activating the aryl hydrocarbon receptor (AhR) protein which upregulates pathways involved in chemical detoxification. AhR, which declines with age, is important for detoxifying the retina. Previous studies show that AhR-deficient mice develop a condition which looks extremely similar to AMD. When contemplating the possibility of boosting AhR via broccoli’s I3C, Buck faculty and lead author Arvind Ramanathan, PhD, knew there was a challenge – I3C is weak activator of AhR. So he used the chemical scaffold of I3C to do a ‘virtual’ screen of a publicly-available database of millions of compounds to find those that were related to I3C but would bind to AhR with more strength. His team came up with 2,2?-aminophenyl indole (2AI) which is ten times more potent than I3C.
“2AI protected human retinal cells in culture from stress,” said Ramanathan. “And it also protected retinal cells in mice from light-mediated damage. We are very excited about the potential for 2AI and look forward to developing it further.” Ramanathan is also excited about the possibility of finding more potent versions of other naturally occurring molecules that show health benefits for age-related diseases. “You would have to eat an unreasonable amount of broccoli and other cruciferous vegetables to get enough of a protective effect to impact AMD,” he said. “This method allows us to capitalize on nature’s wisdom to find related molecules that can deliver therapeutic benefit.”
“2AI prevented cell death in the retinas of mice that were exposed to light stress,” said Buck faculty and co-senior author Deepak Lamba, MBBS, PhD, who is developing stem-cell based therapies for degenerative eye diseases. “Our next step is to study the functional outcomes of treatment with 2AI, something I am eager to do because environmental stress is the major contributor to age-related vision loss.”
Ramanathan said data from the study suggests that at least some of the protective effects of the AhR activation may come via lipids. “We know that eating a diet rich in fish and omega fatty acids reduces the risk of AMD, even though we don’t fully understand the mechanisms involved.” Ramanathan said in this study, 2AI increased levels of the omega-7 lipid palmitoleic acid (PA) suggesting it could be a downstream signal in the anti-inflammatory pathway. Ramanathan said injecting PA also had protective effects on retinal cells in culture and in mice. PA is found in a variety of food including nuts, fish, dairy and vegetable oils. It is found at high concentrations in macadamia and sea buckthorn oil.
The Latest on: Age-related macular degeneration
via Google News
The Latest on: Age-related macular degeneration
- Innovent Announces First Patient Dosed in a Phase I Clinical Trial of IBI302 for the Treatment of Wet AMD on April 17, 2019 at 5:08 pm
"Age-related macular degeneration (AMD) is one of the leading causes of irreversible vision impairment among China's elderly population. Although the efficacy of current therapies for wet AMD is ... […]
- Adverum Announces Clinical Hold, But It Should Not Hinder Its Gene Therapy Path on April 17, 2019 at 7:53 am
Adverum announced that the FDA has placed a clinical hold on one of its gene therapy products known as ADVM-022 to treat patients with wet age-related macular degeneration. Responses for the FDA's ... […]
- A hidden footprint: embryological origins of age related macular degeneration on April 17, 2019 at 6:27 am
To address this, Sivapathasuntharam et al.  examined retinal development in Cfh−/− and Cfh+/− mice and showed significant disruptions at the retinal/RPE interface. However, after retinal ... […]
- US FDA accepts Novartis' BLA for brolucizumab to treat wet age-related macular degeneration on April 16, 2019 at 8:30 pm
Novartis announced that the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular ... […]
- Novartis' BLA Acceptance Allows Entrance Into Large And Turbulent Wet AMD Market on April 16, 2019 at 8:24 pm
Novartis announced that the FDA had accepted its BLA for brolucizumab to treat patients with wet age-related macular degeneration. The company chose to use one of its priority review vouchers to ... […]
- Treatment for Wet Age-Related Macular Degeneration Receives Biologics License Application Approval on April 16, 2019 at 6:54 am
Officials with the FDA have accepted Novartis’ Biologics License Application (BLA) for brolucizumab (RTH258), a humanized single-chain antibody fragment (scFv), for the treatment of wet age-related ... […]
- LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration on April 11, 2019 at 4:49 am
"I am delighted that we are able to offer some of our patients this very exciting new treatment," remarked Professor Ben Burton, Visiting Professor at the University of East Anglia, and ... […]
- Experimental drug ‘slows down macular degeneration’ on April 11, 2019 at 4:45 am
... the growth of abnormal vessels in animal studies of the blinding disease diabetic macular edema and wet age-related macular degeneration. Diabetic macular edema and wet age-related macular ... […]
- Charity gathering shines light on macular disease in north-east on April 7, 2019 at 2:07 am
The event will see the charity giving a brief overview of its activities, as well as an introduction to age-related macular degeneration (AMD) and other macular conditions. Macular disease is the ... […]
- Vitamins, new treatments offer hope for people with macular degeneration on April 5, 2019 at 4:30 am
1 in every 10 Americans will suffer from macular degeneration by age 80, mostly Caucasian women. It is frequently referred to as age-related macular degeneration, or AMD. “The macula is where we get ... […]
via Bing News